"As we launch our product, we are already embarking on customer demonstrations of the EuGeni platform and COVID-19 ART, having received over 50 inbound enquiries from 21 countries."
and this is just the start.
"We aim to approach several key laboratories to trial the EuGeni platform to create momentum for further roll-out."
if (and from my research I think they are) our nasal and saliva tests are as good as management have said, when will the 1st of these 50 enquires, sign an agreement upfront to guarantee to be 1st supplied. it's what the US govt did with Ellume. all the wheels are in motion.
Axxin and operon deals to be signed shortly. think there will be a continuous flow of announcements coming over the coming months.
Ann: Quarterly Activities Report, page-24
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(3.67%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.3¢ | 2.1¢ | $7.812K | 349.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 828094 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 1102151 | 4 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |